Our results demonstrate that Se can ameliorate hepatic injury induced by NAFLD and promote SEPP1 synthesis to regulate the KEAP1/NRF2 pathway, so as to defend against hepatocyte oxidative stress. Here, SELENOP is linked to metabolic dysfunction-associated steatotic liver disease.